GALNT7 and colorectal cancer: Moreover, multivariable analysis of MSI colorectal cancers demonstrated that GALNT7 had significant prognostic value in the AC-ICAM MSI (HR = 0.20; 95% CI, 0.03–0.84; P = 0.047) and GSE39582 MSI (HR = 0.09; 95% CI, 0.01–0.52; P = 0.027) cohorts, independent of other clinical covariates, whereas it showed marginal significance in TCGA MSI cohort (HR = 0.24; 95% CI, 0.04–1.01; P = 0.079; Supplementary Table S4).